Abstract:Objective: To report the clinical outcome of autologous cultured limbal epithelial cell transplantation (CLECT) followed by deep anterior lamellar keratoplasty (DALK) in paediatric eyes and to correlate the clinical outcome with the phenotype of rejuvenated corneal epithelium. Methods: Four patients with total limbal stem cell deficiency (LSCD) underwent autologous CLECT. Cultivated cell sheets were transplanted onto the damaged ocular surface followed by DALK surgery. Excised corneal buttons were subjected to… Show more
“…As for the ex vivo culture, we specifically focus on the following 4 aspects: culture system, the type of AM, and 30,39,49 20,34,46,47 30,39,49 Y 37,42 …”
Section: Ex Vivo Culture Methodsmentioning
confidence: 99%
“…may be used as a cell substrate in the ex vivo culture. But human amniotic membrane (HAM), which promotes epithelialization, inhibits fibrosis, has anti-inflammatory and antiangiogenic properties, and possesses antimicrobial and antiviral properties and a high hydraulic conductivity, 22,23 with low or no immunogenicity, 24 has become the widely used material [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42] acting as a surrogate environmental stem cell niche. 43 The use of ex vivo cultured LESCs to treat corneal LSCD in humans was first described by Pellegrini et al 44 in 1997. Subsequently, plenty of case series and reviews have reported the efficiency and evidence of this treatment.…”
mentioning
confidence: 99%
“…43 The use of ex vivo cultured LESCs to treat corneal LSCD in humans was first described by Pellegrini et al 44 in 1997. Subsequently, plenty of case series and reviews have reported the efficiency and evidence of this treatment. 12,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][45][46][47] However, with the lack of sufficient cases or valid measurements, they failed to provide a convincing assessment of this surgery. Moreover, there is controversy regarding the clinical outcome between different sources of limbal stem cells, such as autograft and allograft.…”
CLET is efficacious in patients with LSCD, and no difference both in success rate and visual acuity outcome between autograft and allograft was found. Overall safety profile was good, with most side effects being transient and amenable to subsequent treatments. The long-term results of autograft and allograft will inform future treatment algorithms and techniques with random control trials and better-designed analysis.
“…As for the ex vivo culture, we specifically focus on the following 4 aspects: culture system, the type of AM, and 30,39,49 20,34,46,47 30,39,49 Y 37,42 …”
Section: Ex Vivo Culture Methodsmentioning
confidence: 99%
“…may be used as a cell substrate in the ex vivo culture. But human amniotic membrane (HAM), which promotes epithelialization, inhibits fibrosis, has anti-inflammatory and antiangiogenic properties, and possesses antimicrobial and antiviral properties and a high hydraulic conductivity, 22,23 with low or no immunogenicity, 24 has become the widely used material [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42] acting as a surrogate environmental stem cell niche. 43 The use of ex vivo cultured LESCs to treat corneal LSCD in humans was first described by Pellegrini et al 44 in 1997. Subsequently, plenty of case series and reviews have reported the efficiency and evidence of this treatment.…”
mentioning
confidence: 99%
“…43 The use of ex vivo cultured LESCs to treat corneal LSCD in humans was first described by Pellegrini et al 44 in 1997. Subsequently, plenty of case series and reviews have reported the efficiency and evidence of this treatment. 12,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][45][46][47] However, with the lack of sufficient cases or valid measurements, they failed to provide a convincing assessment of this surgery. Moreover, there is controversy regarding the clinical outcome between different sources of limbal stem cells, such as autograft and allograft.…”
CLET is efficacious in patients with LSCD, and no difference both in success rate and visual acuity outcome between autograft and allograft was found. Overall safety profile was good, with most side effects being transient and amenable to subsequent treatments. The long-term results of autograft and allograft will inform future treatment algorithms and techniques with random control trials and better-designed analysis.
“…The successful restoration of damaged ocular surface may be due to the regeneration of demolished LESC niche, which may in turn repopulate the stem cells crucial for maintaining the epithelial integrity. In one of our report 34 , we further described our experience using a meticulous approach to reconstruct the severely damaged ocular surface by combining our previously reported LSCT method with the deep anterior lamellar corneal transplantation using donor corneas to restore corneal clarity and vision by reducing corneal vascularisation. Further more histopathology of excised host lamellar corneal buttons demonstrated organised corneal epithelial morphology with the expression of CK3/12 in rejuvenated corneal.…”
mentioning
confidence: 99%
“…Further more histopathology of excised host lamellar corneal buttons demonstrated organised corneal epithelial morphology with the expression of CK3/12 in rejuvenated corneal. 34 …”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.